Skip to main content
Clinical Trials/NCT04400422
NCT04400422CompletedNot Applicable

Experience of Using Lipano in Children With LCHAD (Long Chain Fatty Acid Oxidation Disorder)

Dr. Schär AG / SPA1 site in 1 country5 target enrollmentStarted: June 20, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
5
Locations
1
Primary Endpoint
Gastrointestinal tolerance: questionnaire

Study Overview

Brief Summary

This is a market research, observational study to evaluate the tolerability and acceptability of an MCT based formula for infants and young people with long chain fatty acid oxidation disorder from birth to 18 months. Patients with a confirmed diagnosis of a fatty acid oxidation disorder, which requires a specialist diet including MCT will be included in this study

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
— to 18 Months (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosis of a fatty acid oxidation disorder requiring a ketogenic or a specialist diet as part of their treatment, which includes MCT.
  • •Patients from birth to 18 months
  • •Written informed consent obtained from patient or parental caregiver

Exclusion Criteria

  • •Presence of serious concurrent illness
  • •Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements
  • •Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.
  • •Any patients having taken antibiotics over the previous 2 weeks leading up to the study
  • •Patients over 18 months of age

Arms & Interventions

Lipano MCT formula

Experimental

Kanso Lipano will be consumed daily for 3 months each to assess tolerability and compliance

Intervention: Lipano formula (Dietary Supplement)

Outcomes

Primary Outcomes

Gastrointestinal tolerance: questionnaire

Time Frame: 90 days

Daily questionnaire detailing any GI symptoms, severity and change from usual The collection of daily data about the gastrointestinal tolerance of the product

Product compliance

Time Frame: 90 days

Daily questionnaire on amounts offered and amounts actually consumed, compared to recommended amount.

Product palatability

Time Frame: 90 days

Questionnaire data captured to evaluate taste

Product acceptability

Time Frame: 90 days

Brief tick-box questionnaire on overall liking and acceptability of product

Secondary Outcomes

  • Biochemistry stability - creatine kinase(90 days)
  • Biochemistry stability - liver enzymes(90 days)
  • Anthropometry 1(90 days)
  • Anthropometry 2(90 days)

Investigators

Sponsor
Dr. Schär AG / SPA
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials